meta_pixel
Tapesearch Logo
Log in
Science Quickly

'Where Are Vaccines for Little Kids?' and the Latest on Long COVID

Science Quickly

Scientific American

Science

4.31.4K Ratings

🗓️ 31 May 2022

⏱️ 9 minutes

🧾️ Download transcript

Summary

Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks,  Scientific American ’s senior health editors  Tanya Lewis  and  Josh Fischman  catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between. You can listen to all past episodes  here . 

Transcript

Click on a timestamp to play from that location

0:00.0

Imagine you, you in a nice comfy seat with your hands behind your head, taking in the views,

0:09.6

instead of taking on the road, maybe even taking a nap. That's the bliss of getting where you

0:15.5

need to go without worrying about driving. Book your train journey via avantiwascoast.co.uk

0:23.0

and we'll take you there. Avantiwascoast, feel good travel.

0:30.2

Hi and welcome to COVID Quickly, a scientific American podcast series.

0:44.6

This is your fast track update on the COVID pandemic. We bring you up to speed on the science behind

0:49.9

the most urgent questions about the virus and the disease. We demystify the research and help

0:55.1

you understand what it really means. I'm Tanya Lewis. I'm Josh Fishman. And we are

1:00.0

scientific American senior health editors. Today vaccines for the littlest kids may be almost here.

1:06.4

And new evidence about long COVID shows who gets it most often and what the most common symptoms are.

1:15.0

It's been nearly a year and a half since COVID vaccines were authorized for adults in the U.S.

1:20.0

Yet kids under five are still not eligible, even though testing in children began over six months

1:25.5

ago. Could this be about to change, Tanya? Possibly. I can understand why many parents are frustrated.

1:31.6

They've been told for months that a vaccine is right around the corner, but they have been some

1:35.9

promising developments. Like what? Have there been good results from these tests? Just a couple of

1:41.4

weeks ago, vaccine maker Moderna announced it was filing for emergency use authorization for its

1:46.5

vaccine for kids ages six months to six years. And Pfizer recently announced in a press release

1:52.0

that its vaccine was 80% effective at preventing symptomatic COVID in kids under five, although they

1:57.4

haven't made the data public yet. Does that get us any closer to getting a green light from the FDA, though?

2:03.2

Well, Siam contributor Charlie Schmidt asked experts about when we can expect a vaccine for the

2:08.0

littlest ones, what the reasons are for the hold up and more. The FDA's advisory committee for

2:13.7

vaccines is scheduled to meet June 8th, 21st and 22nd to discuss making younger children eligible.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Scientific American, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Scientific American and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.